Skip to main content


Press Releases

September 18, 2017
GAITHERSBURG, Md., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at approximately $63 million by the Biomedical Advanced Research and Development Authority (BARDA) to develop an antidote spray device for the trea...


Corporate Headquarters Ribbon Cutting

Lynn R. Kieffer 
TEL 240-631-3391 

Robert Burrows 
TEL 240-631-3280